ACCESSION: MSBNK-SMB_Measured-HSA001P0114025
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.17, Processed 2025.02.17, Annotated 2025.03.05, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyoshu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 32
COMMENT: RAW_SPEC {'ProcedureBlank_2351': {'bp': 1692850.0, 'sum': 3988546.0}, '13_posi_2769': {'bp': 699443.0, 'sum': 1891317.0}, '3_posi_2747': {'bp': 547554.0, 'sum': 1540416.0}, '5_posi_2160': {'bp': 1425798.0, 'sum': 4144350.0}, 'ProcedureBlank_2561': {'bp': 1520553.0, 'sum': 3496621.0}, '11_posi_2789': {'bp': 530422.0, 'sum': 1474293.0}, '17_posi_2809': {'bp': 532765.0, 'sum': 1584166.0}, '14_posi_2728': {'bp': 650987.0, 'sum': 2054624.0}, '4_posi_2246': {'bp': 1613926.0, 'sum': 4320098.0}, '15_posi_2750': {'bp': 751655.0, 'sum': 2129453.0}, '18_posi_2790': {'bp': 778092.0, 'sum': 2339931.0}, '2_posi_2661': {'bp': 803084.0, 'sum': 2348587.0}, '11_posi_2243': {'bp': 1564330.0, 'sum': 4263345.0}, '17_posi_2265': {'bp': 1640120.0, 'sum': 4536843.0}, '6_posi_2707': {'bp': 698084.0, 'sum': 2102858.0}, '7_posi_2663': {'bp': 863960.0, 'sum': 2432249.0}, '1_posi_2155': {'bp': 1619310.0, 'sum': 4490381.0}, '10_posi_2727': {'bp': 709124.0, 'sum': 2069577.0}, '8_posi_2704': {'bp': 742796.0, 'sum': 2266819.0}, '3_posi_2659': {'bp': 793929.0, 'sum': 2437618.0}, '6_posi_2305': {'bp': 1639088.0, 'sum': 4571335.0}, '9_posi_2724': {'bp': 748075.0, 'sum': 2244290.0}, '1_posi_2645': {'bp': 792393.0, 'sum': 2383803.0}, '3_posi_2204': {'bp': 1619395.0, 'sum': 4172101.0}, '11_posi_2708': {'bp': 769084.0, 'sum': 2292789.0}, '15_posi_2222': {'bp': 1325118.0, 'sum': 3503608.0}, '10_posi_2204': {'bp': 1550832.0, 'sum': 4097566.0}, '18_posi_2328': {'bp': 1448384.0, 'sum': 3794102.0}, '4_posi_2728': {'bp': 584965.0, 'sum': 1654143.0}, 'ProcedureBlank_2477': {'bp': 1619708.0, 'sum': 3874034.0}, '13_posi_2183': {'bp': 1321611.0, 'sum': 3520139.0}, '14_posi_2198': {'bp': 1466519.0, 'sum': 4214240.0}}
COMMENT: RETENTION_TIME_STDEV 0.487
COMMENT: PRECURSOR_M/Z_RAW 114.066269
COMMENT: PRECURSOR_M/Z_STDEV 0.000026
COMMENT: PRECURSOR_IN_MS1 mz 114.066251; int 120.487; delta(ppm) 1.437476
COMMENT: PROPOSED_CHARGE_STATE +1; mz 115.069618; int 4.947; cor 0.957
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.548; C4H7N3O; [M+H]+; delta(ppm) 0.548386
COMMENT: PROPOSED_MF MS-FINDER 3.314; C4H7N3O; [M+H]+; delta(ppm) 0.540919
COMMENT: PROPOSED_MF SIRIUS5_Sirius 29.170; C4H7N3O; [M+H]+; delta(ppm) 0.540919
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C4H7N3O; [M+H]+; delta(ppm) 0.540919
COMMENT: PROPOSED_MF SIRIUS6_Sirius 28.543; C4H7N3O; [M+H]+; delta(ppm) 0.540919
COMMENT: PROPOSED_MF SIRIUS6_Sirius 5.528; C6H9O2; [M+H]+; delta(ppm) -11.229865
COMMENT: PROPOSED_MF SIRIUS6_Sirius -1.746; C2H5N6; [M+H]+; delta(ppm) 12.311981
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C4H7N3O; [M+H]+; delta(ppm) 0.540919
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.873; DDRJAANPRJIHGJ-UHFFFAOYSA-N; [M+H]+; Creatinine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.157; PPVUWDCETZMPLT-UHFFFAOYSA-N; [M+H]+; 1,3-dihydropyrazole-2-carboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.101; BTXYOFGSUFEOLA-UHFFFAOYSA-N; [M+H]+; 2-amino-1-methyl-imidazol-4-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.009; HZDLDFBKYBGNHG-UHFFFAOYSA-N; [M+H]+; 3-(N-Nitrosomethylamino)propionitrile
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; PPVUWDCETZMPLT-UHFFFAOYSA-N; [M+H]+; 1,3-dihydropyrazole-2-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.849; DDRJAANPRJIHGJ-UHFFFAOYSA-N; [M+H]+; Creatinine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.735; BTXYOFGSUFEOLA-UHFFFAOYSA-N; [M+H]+; 2-amino-1-methyl-imidazol-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.689; HZDLDFBKYBGNHG-UHFFFAOYSA-N; [M+H]+; 3-(N-Nitrosomethylamino)propionitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.907; DDRJAANPRJIHGJ-UHFFFAOYSA-N; [M+H]+; 2-amino-3-methyl-4H-imidazol-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.307; HZDLDFBKYBGNHG-UHFFFAOYSA-N; [M+H]+; N-(2-cyanoethyl)-N-methylnitrous amide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.143; FOOFYKFJNMAAQE-UHFFFAOYSA-N; [M+H]+; N-ethyl-1,3,4-oxadiazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.109; KXLLKSHFFVQKTQ-UHFFFAOYSA-N; [M+H]+; 2-cyanoethylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.033; HGPUJQWMCPURNO-UHFFFAOYSA-N; [M+H]+; 3-ethyl-1,2,4-oxadiazol-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.944; XHSTYRIUVMKGDX-UHFFFAOYSA-N; [M+H]+; 5-ethyl-1,3,4-oxadiazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.926; BVNFZLFQKJYVDJ-UHFFFAOYSA-N; [M+H]+; 3,4-dimethyl-1H-1,2,4-triazol-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.923; MKSFCAQPDWJPND-UHFFFAOYSA-N; [M+H]+; 5-(aminomethyl)-1,2-dihydropyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.922; VUYWQWFWWHLKFG-UHFFFAOYSA-N; [M+H]+; 4-amino-5-methyl-1,2-dihydropyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.911; MTHUPGKUEISSDE-UHFFFAOYSA-N; [M+H]+; 2-amino-N-(cyanomethyl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.905; XGKOIOPVLYCTRF-UHFFFAOYSA-N; [M+H]+; 5-amino-2-methyl-4H-pyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.899; IRPLFUJJHBGEAL-UHFFFAOYSA-N; [M+H]+; 3-amino-2-methyl-1H-pyrazol-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.899; AUZHYHBJZVEQNI-UHFFFAOYSA-N; [M+H]+; 4-amino-2-methyl-1H-pyrazol-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.895; YGVFIVSNVVUSCS-UHFFFAOYSA-N; [M+H]+; 5-amino-2-methyl-1H-pyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.888; NZORXPUYHVZTQG-UHFFFAOYSA-N; [M+H]+; (3-amino-1H-pyrazol-5-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.870; LFSXUCZAZSQBPW-UHFFFAOYSA-N; [M+H]+; 1-(1,2,4-oxadiazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.870; HUSLEZCKWCUICB-UHFFFAOYSA-N; [M+H]+; 2-(1,2,4-oxadiazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.853; HJEVQOSZWIDFQJ-UHFFFAOYSA-N; [M+H]+; 2-(2H-triazol-4-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.851; PKHVUMMJMYKRNO-UHFFFAOYSA-N; [M+H]+; 2-(triazol-1-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.849; DLLDJWMWMVUIDZ-UHFFFAOYSA-N; [M+H]+; (3-methyltriazol-4-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.848; XKKMMJLWDOKNEW-UHFFFAOYSA-N; [M+H]+; (1-methyltriazol-4-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.822; CIFUFRVSHZKBEO-UHFFFAOYSA-N; [M+H]+; (4-methyl-1,2,4-triazol-3-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.822; YOSYLAYVXLOORB-UHFFFAOYSA-N; [M+H]+; 2-(1,2,4-triazol-4-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.809; KNIARYZRPMJYFH-UHFFFAOYSA-N; [M+H]+; 2-(1H-1,2,4-triazol-5-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.807; XJUQLFVCCWNFJJ-UHFFFAOYSA-N; [M+H]+; N-methyl-1-(1,2,4-oxadiazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.807; WYZRLXYOIMXEBO-UHFFFAOYSA-N; [M+H]+; 1-(1H-1,2,4-triazol-5-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.758; CLVALLQETQTQMV-UHFFFAOYSA-N; [M+H]+; 2-(1,2,4-triazol-1-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.755; QUAQZVSGXQVIEP-UHFFFAOYSA-N; [M+H]+; (2-methyl-1,2,4-triazol-3-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.752; RTCYUGLJCAPLPD-UHFFFAOYSA-N; [M+H]+; (2-methyltriazol-4-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.749; PFBCKBGKRFYNLE-UHFFFAOYSA-N; [M+H]+; (5-methyl-2H-triazol-4-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.739; HKIXGXYGOILGSX-UHFFFAOYSA-N; [M+H]+; 2-(1,2,4-oxadiazol-5-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.739; CIHQZPVUYBHNQO-UHFFFAOYSA-N; [M+H]+; 1-(1,2,4-oxadiazol-5-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.738; WEDYTSQNYJKOPC-UHFFFAOYSA-N; [M+H]+; (1-methyl-1,2,4-triazol-3-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.708; BMTFHVKZYIOHBE-UHFFFAOYSA-N; [M+H]+; (5-methyl-1H-1,2,4-triazol-3-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.690; YWXPPKJKSSLZOD-UHFFFAOYSA-N; [M+H]+; 5-(methoxymethyl)-1H-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.689; DSFUCCQCXNNWLA-UHFFFAOYSA-N; [M+H]+; 3-methoxy-1H-pyrazol-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.685; OTERRMWTPZGJLB-UHFFFAOYSA-N; [M+H]+; 4-ethyl-1,2,5-oxadiazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.681; YKTPXKSUWIQBML-UHFFFAOYSA-N; [M+H]+; (4-methyl-1,2,5-oxadiazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.676; YUTNQQHHUYYBFA-UHFFFAOYSA-N; [M+H]+; N-methyl-1-(1,2,4-oxadiazol-5-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.661; NPBUMVMXXGQOEG-UHFFFAOYSA-N; [M+H]+; (3-methyl-1,2,4-oxadiazol-5-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.661; KPBSGOLXLCARIL-UHFFFAOYSA-N; [M+H]+; (5-methyl-1,2,4-oxadiazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.646; HNXYWYOVPHLAQF-UHFFFAOYSA-N; [M+H]+; N,4-dimethyl-1,2,5-oxadiazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.254; OMFADAFZDYXVOK-UHFFFAOYSA-N; [M+H]+; 5-ethyl-1,2,4-oxadiazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.237; GZDJNVITGJORKZ-UHFFFAOYSA-N; [M+H]+; ethyl N'-cyanocarbamimidate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.231; LODVFGWSULLZAU-UHFFFAOYSA-N; [M+H]+; 4-methoxy-1H-pyrazol-5-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -128.364; CMIPWACBRYWGPN; [M+H]+; 1-Cyano-2,3-dimethylisourea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -138.115; KXLLKSHFFVQKTQ; [M+H]+; 2-Cyanoethylurea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -168.431; DDRJAANPRJIHGJ; [M+H]+; Kreatinin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -198.026; HZDLDFBKYBGNHG; [M+H]+; 3-Methylnitrosaminopropionitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -201.421; OMFADAFZDYXVOK; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -207.379; HGPUJQWMCPURNO; [M+H]+; Ambcb4035725
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -218.230; XHSTYRIUVMKGDX; [M+H]+; 2-NH2-5-ET-1,3,4-oxadiazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -271.076; OTERRMWTPZGJLB; [M+H]+; 4-ethyl-1,2,5-oxadiazol-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -273.831; RTCYUGLJCAPLPD; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -287.598; DLLDJWMWMVUIDZ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -289.427; CLVALLQETQTQMV; [M+H]+; triazolylethanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -324.191; IRPLFUJJHBGEAL; [M+H]+; 5-amino-1-methyl-1H-pyrazol-3-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -355.238; PKHVUMMJMYKRNO; [M+H]+; 2-(1-triazolyl)ethanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -367.443; MKSFCAQPDWJPND; [M+H]+; Azamuscimol
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.409; CMIPWACBRYWGPN; [M+H]+; 1-Cyano-2,3-dimethylisourea
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -62.502; DDRJAANPRJIHGJ; [M+H]+; Kreatinin
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -93.011; PPVUWDCETZMPLT; [M+H]+; 5-Dihydro-1h-pyrazole-1-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -120.882; KXLLKSHFFVQKTQ; [M+H]+; 2-Cyanoethylurea
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -122.534; XGKOIOPVLYCTRF; [M+H]+; 3-amino-1-methyl-4,5-dihydro-1H-pyrazol-5-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -128.786; HZDLDFBKYBGNHG; [M+H]+; 3-(Methyl-D3-nitrosoamino)propionitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -131.121; CMIPWACBRYWGPN; [M+H]+; 1-Cyano-2,3-dimethylisourea
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -147.033; FOOFYKFJNMAAQE; [M+H]+; N-ethyl-1,3,4-oxadiazol-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -159.118; BVNFZLFQKJYVDJ; [M+H]+; 3H-1,2,4-Triazol-3-one, 2,4-dihydro-4,5-dimethyl-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -163.643; XHSTYRIUVMKGDX; [M+H]+; 5-Ethyl-1,3,4-oxadiazol-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -197.605; HGPUJQWMCPURNO; [M+H]+; 3-Ethyl-1,2,4-oxadiazol-5-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.324; DDRJAANPRJIHGJ; [M+H]+; Kreatinin
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C4H8N3O1; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 5.037
MS$FOCUSED_ION: PRECURSOR_M/Z 114.066250
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-03k9-6900000000-282a15e8948ab65a3cd2
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  69.0699021 5.4191 69.070527 1.9690 2.70 -0.2786 28 ?
  70.0651588 7.0242 70.065778 1.1132 2.74 0.4951 23 f{C4H8N1}/0.47ppm,p-N2O1
  71.0603868 999.0000 71.061000 0.2392 0.00 0.5282 32 f{C3H7N2}/0.17ppm,p-C1H1N1O1
  72.0443935 6.3138 72.045000 1.7350 2.01 0.8434 30 f{C3H6N1O1}/0.05ppm,p-C1H2N2
  79.0542429 6.9814 79.054790 1.3914 3.43 -0.2240 32 ?
  85.0760708 6.8910 85.076550 1.6103 1.84 0.3185 31 ?
  86.0601033 9.0863 86.060570 1.1271 2.43 0.5836 32 f{C4H8N1O1}/0.73ppm,p-N2
  86.0712835 39.8471 86.071750 0.7436 14.88 0.9648 32 f{C3H8N3}/0.11ppm,p-C1O1
  86.0793193 5.8435 86.079786 1.9865 1.67 0.4773 23 ?
  96.0807976 6.9401 96.081150 1.4363 3.71 -0.1745 32 ?
  97.0760430 7.3069 97.076388 2.0808 1.86 0.5266 30 ?
  104.0819341 9.6541 104.082220 1.5373 4.43 0.8185 31 ?
  114.0662677 494.9534 114.066450 0.5435 162.38 1.0000 32 f{C4H8N3O1}/0.70ppm,p
  114.0914280 193.5733 114.091610 0.5872 68.80 0.3127 32 ?
  114.1025682 939.4385 114.102750 0.3593 22.52 0.5598 32 ?
PK$NUM_PEAK: 15
PK$PEAK: m/z int. rel.int.
  69.069902 5.42 5
  70.065159 7.02 7
  71.060387 999.00 999
  72.044393 6.31 6
  79.054243 6.98 6
  85.076071 6.89 6
  86.060103 9.09 9
  86.071283 39.85 39
  86.079319 5.84 5
  96.080798 6.94 6
  97.076043 7.31 7
  104.081934 9.65 9
  114.066268 494.95 494
  114.091428 193.57 193
  114.102568 939.44 939
//
